Interestingly, among prostate cancer cell lines, MYO18A expression was shown to be higher in a cell line with higher metastatic potential, and the authors inferred, based on knockdown studies, that effects of MYO18A on actin organization and motility could contribute to metastasis (Makowska et al., 2015). Here, MYO18A is linked to prostate cancer.